Named after the infamously high-pitched, hapless yet persistent character on "The Simpsons," this newish tool (released in ...

AI launches Grok Business & Enterprise AI plans with enterprise security, no data training, and higher limits.

The runaway winner among Minnesota-based public company stocks in 2025 was a company with no revenue but huge promise. Plymouth-based Celcuity, a clinical stage biopharmaceutical company, is ...

Rated 9.8 out of 10 in severity, the flaw could allow a remote attacker to gain unauthorized access to applications.

Utilize AI to analyze application runtime data (e.g., rendering time, communication latency), obtain optimization suggestions (such as reducing component re-rendering, reusing hardware connections), ...

Samsung C&T's engineering and construction group said on the 14th that it signed a memorandum of understanding with Synthos Green Energy, which leads Poland's Small Modular Reactor (SMR) program and ...

BXP has closed on a deal to build a new office project in Washington, D.C., for a law firm, another big leasing win in the city for the publicly traded developer. The Boston-based REIT has been in ...

USB-C is everywhere in 2025. If you've felt like every new device you buy, from smartphones to laptops and tablets, uses a USB-C port for charging, you're not imagining things. USB-C has quickly ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

One of the great myths of programmatic advertising is the illusion of algorithms replacing humans. In truth, the programmatic industry relies heavily on human relationships and handshake agreements.

X has announced a new pay-per-use self-serve API model in hopes of luring developers back to the platform. Credit: Gabby Jones/Bloomberg via Getty Images Good news! Elon Musk's X has heard the cries ...

With a mega investment of 6.5 billion dollars, Eli Lilly and Company has plans to develop a next-generation synthetic medicine active pharmaceutical product facility in Texas, USA. The facility will ...